HISTOMORPHOLOGIC VALIDATION OF THALLIUM AND 18FDG PET CRITERIA FOR VIABILITY
HISTOMORPHOLOGIC VALIDATION OF THALLIUM AND 18FDG PET CRITERIA FOR VIABILITY
批准号:
3757718
负责人:
V DILSIZIAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
chronic disease /disorder diagnosis quality /standard fluorine heart revascularization heart transplantation human subject human tissue intracardiac volume muscle cells myocardial ischemia /hypoxia myocardium disorder positron emission tomography prognosis radionuclide diagnosis radionuclide imaging /scanning rest stainings stress thallium
中文摘要
铊再注射和18F-氟脱氧葡萄糖(FDG)正电子
发射断层摄影(PET)协议已经显示出与
预测血运重建后机能不全区域的功能恢复。
虽然铊再注射和FDG PET之间的良好相关性,
令人鼓舞的是,没有定量的组织形态学“金标准”,
在人类受试者中验证铊的可行性信息,
FDG 因此,我们前瞻性研究了15名非糖尿病、慢性
缺血性心肌病患者列出的心脏移植,
静息时应力再分布铊断层扫描和FDG PET。 8分
已接受心脏移植,其中6例
由2名经验丰富的病理学家进行组织形态学分析,
铊和PET结果。 将离体心脏沿短轴方向切开
切片(平均厚度7 mm)和来自
在用
天狼星红。 每个断层图像分为8个区域,
分别计算每个区域中活肌细胞的面积百分比。
对于铊再分布、再注射和FDG PET研究,
铊负荷图像系列上计数最多的心肌区域
被用作该患者的正常参考区域。 在48个
匹配的组织形态学,铊和FDG区域分析,而
再分布时的铊吸收百分比(平均值)与
71.5± 22.3)和活肌细胞%(通过组织形态学分析)
(mean 74.9 ± 15.4,r= 0.56,小于0.001),相关系数为
用铊再注射改善(平均73.7 ± 23.7,r= 0.67,
001)和FDG PET(平均76.3 ± 19.4,r= 0.67,p <0.001)。
0.001)。 这些数据提供了组织形态学证实,
铊和FDG摄取量的大小正确估计分布
活的心肌细胞的数量
英文摘要
Both thallium reinjection and 18F-fluorodeoxyglucose (FDG) positron
emission tomography (PET) protocols have been shown to correlate and
predict functional recovery of asynergic regions after revascularization.
While such good correlation between thallium reinjection and FDG PET is
encouraging, there is no quantitative, histomorphologic "gold standard"
in human subjects that validate the viability information of thallium and
FDG. Therefore, we prospectively studied 15 nondiabetic, chronic
ischemic cardiomyopathy patients listed for cardiac transplantation, with
stress-redistribution thallium tomography and FDG PET at rest. Eight pts
have received cardiac transplantation, of whom 6 have had
histomorphologic analysis by 2 experienced pathologist blinded to the
thallium and PET results. The explanted hearts were sliced in short-axis
sections (mean thickness 7 mm) and the volume fraction of myocytes from
midventricular slices were studied quantitatively after staining with
Picro Sirius red. Each tomogram was divided into 8 regions and the
percent area of viable myocytes in each region was calculated separately.
For thallium redistribution, reinjection, and FDG PET studies, the
myocardial region with maximum counts on the thallium stress image series
was used as the normal reference region for that patient. Among the 48
matched histomorphologic, thallium and FDG regions analyzed, while there
was a good correlation between % thallium uptake on redistribution (mean
71.5 plus/minus 22.3) and % viable myocytes by histomorphologic analysis
(mean 74.9 plus/minus 15.4, r=.56, pless than0.001), the correlation was
improved with thallium reinjection (mean 73.7 + 23.7, r=.67,
plessthan0.001) and FDG PET (mean 76.3 plus/minus 19.4, r=.67, p less
than0.001). These data provide histomorphologic confirmation that the
magnitude of thallium and FDG uptake correctly estimate the distribution
of viable myocytes in human subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOMOGRAPHIC RADIONUCLIDE ANGIOGRAPHY
-
批准号:5203588
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION
-
批准号:3757707
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
IDENTIFICATION OF VIABLE MYOCARDIUM IN LEFT VENTRICULAR DYSFUNCTION
-
批准号:3779626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
ASSESSMENT OF MYOCARDIAL VIABILITY WITH TECHNETIUM-99M SESTAMIBI
-
批准号:3843415
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
COMPARISON OF SESTAMIBI DEFECTS WITH KNOWN INDICES OF ADVERSE PROGNOSIS
-
批准号:3757717
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
CONGESTIVE HEART FAILURE--NUCLEAR STUDIES
-
批准号:6162743
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
-
批准号:2576840
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
-
批准号:5203580
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
HISTOMORPHOLOGIC CORRELATION OF NUCLEAR STUDIES
-
批准号:5203585
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
ASSESSMENT OF MYOCARDIAL VIABILITY BY THALLIUM SCINTIGRAPHY
-
批准号:3858129
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--NUCLEAR TECHNIQUES
-
批准号:6162742
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL VIABILITY--POSITRON EMISSION TOMOGRAPHY
-
批准号:6162768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
PERSISTENT REGIONAL WALL MOTION ABNORMALITIES FOLLOWING EXERCISE
-
批准号:3757710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
POST STRESS LEFT VENTRICULAR CONTRACTILE DYSFUNCTION
-
批准号:6162767
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
PERSISTENT REGIONAL WALL MOTION ABNORMALITIES FOLLOWING EXERCISE
-
批准号:3779635
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
MYOCARDIAL BLOOD FLOW CHANGES DURING LOW DOSE DOBUTAMINE/METABOLIC IMAGING
-
批准号:6162766
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
CONGESTIVE HEART FAILURE--NUCLEAR STUDIES
-
批准号:5203589
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位:
CONGESTIVE HEART FAILURE--NUCLEAR STUDIES
-
批准号:2576844
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:V DILSIZIAN
-
依托单位: